Logo image of TCJH

TOP KINGWIN LTD-A (TCJH) Stock Fundamental Analysis

NASDAQ:TCJH - Nasdaq - KYG8923U1031 - Common Stock - Currency: USD

0.5  +0.01 (+2.33%)

Fundamental Rating

3

TCJH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 225 industry peers in the Capital Markets industry. TCJH has a great financial health rating, but its profitability evaluates not so good. TCJH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TCJH had negative earnings in the past year.
In the past year TCJH has reported a negative cash flow from operations.
TCJH Yearly Net Income VS EBIT VS OCF VS FCFTCJH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M

1.2 Ratios

TCJH has a worse Return On Assets (-24.89%) than 97.21% of its industry peers.
TCJH has a Return On Equity of -34.40%. This is amonst the worse of the industry: TCJH underperforms 89.77% of its industry peers.
Industry RankSector Rank
ROA -24.89%
ROE -34.4%
ROIC N/A
ROA(3y)-0.26%
ROA(5y)N/A
ROE(3y)1.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TCJH Yearly ROA, ROE, ROICTCJH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 20 -20 40 -40 60 80

1.3 Margins

TCJH has a Gross Margin of 65.84%. This is in the better half of the industry: TCJH outperforms 65.12% of its industry peers.
TCJH's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for TCJH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
TCJH Yearly Profit, Operating, Gross MarginsTCJH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, TCJH has more shares outstanding
TCJH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TCJH Yearly Shares OutstandingTCJH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M
TCJH Yearly Total Debt VS Total AssetsTCJH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

TCJH has an Altman-Z score of 19.49. This indicates that TCJH is financially healthy and has little risk of bankruptcy at the moment.
TCJH has a Altman-Z score of 19.49. This is amongst the best in the industry. TCJH outperforms 98.60% of its industry peers.
TCJH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.49
ROIC/WACCN/A
WACCN/A
TCJH Yearly LT Debt VS Equity VS FCFTCJH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M 6M

2.3 Liquidity

A Current Ratio of 2.48 indicates that TCJH has no problem at all paying its short term obligations.
TCJH's Current ratio of 2.48 is fine compared to the rest of the industry. TCJH outperforms 75.35% of its industry peers.
A Quick Ratio of 2.48 indicates that TCJH has no problem at all paying its short term obligations.
TCJH's Quick ratio of 2.48 is fine compared to the rest of the industry. TCJH outperforms 75.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 2.48
TCJH Yearly Current Assets VS Current LiabilitesTCJH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

TCJH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -184.12%.
Looking at the last year, TCJH shows a very strong growth in Revenue. The Revenue has grown by 74.65%.
TCJH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 59.90% yearly.
EPS 1Y (TTM)-184.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.78%
Revenue 1Y (TTM)74.65%
Revenue growth 3Y59.9%
Revenue growth 5YN/A
Sales Q2Q%724.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TCJH Yearly Revenue VS EstimatesTCJH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2M 4M 6M
TCJH Yearly EPS VS EstimatesTCJH Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TCJH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TCJH Price Earnings VS Forward Price EarningsTCJH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TCJH Per share dataTCJH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TCJH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TOP KINGWIN LTD-A

NASDAQ:TCJH (10/18/2024, 8:09:43 PM)

0.5

+0.01 (+2.33%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap91.48M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16.78
P/FCF N/A
P/OCF N/A
P/B 12.35
P/tB 20.86
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.03
BVpS0.04
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.89%
ROE -34.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.84%
FCFM N/A
ROA(3y)-0.26%
ROA(5y)N/A
ROE(3y)1.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 117.59%
Cap/Sales 1.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.48
Quick Ratio 2.48
Altman-Z 19.49
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)205.32%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-184.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)74.65%
Revenue growth 3Y59.9%
Revenue growth 5YN/A
Sales Q2Q%724.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-169.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.94%
OCF growth 3YN/A
OCF growth 5YN/A